Lithium versus lamotrigine in bipolar disorder type II: protocol for a single-blinded, pragmatic, randomised controlled trial (the LiLa-Bipolar RCT).
Fredskild Mette Ungermann, Fussing Bruun Caroline Fussing, Miskowiak Kamilla Woznica, +4 more·BMJ open
INTRODUCTION: Bipolar II disorder (BDII) accounts for the majority of patients with bipolar disorder (BD), yet evidence supporting first-line mood stabilising treatment with lithium and lamotrigine is scarce, and the certainty of the evidence is very low. This highlights a critical evidence gap within psychiatric care.…